Skip to main content
. Author manuscript; available in PMC: 2011 Dec 7.
Published in final edited form as: Cancer Immunol Immunother. 2009 Jan 28;58(10):1545–1556. doi: 10.1007/s00262-009-0662-2

Fig. 2.

Fig. 2

Prevention of distant tumor growth by intratumoral injection of α-gal glycolipids. The figure describes development of tumors in the left flank from inoculates of 104 B16 cells, administered subcutaneously at the same time as the 106 B16 cells were administered subcutaneously in the right flank. (a) Development of the distant tumor in mice receiving two α-gal glycolipids injections into the right flank “primary” tumor (n = 8). b Development of the distant tumor in mice with “primary” tumor injected twice with PBS (n =8)